Log in to save to my catalogue

Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipi...

Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_811b660f49504906b2cb44528d6f672b

Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipidemia, and oxidative stress in diabetic rats

About this item

Full title

Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipidemia, and oxidative stress in diabetic rats

Publisher

Iran: Wolters Kluwer - Medknow Publications

Journal title

International journal of preventive medicine, 2016-01, Vol.7 (1), p.102-102

Language

English

Formats

Publication information

Publisher

Iran: Wolters Kluwer - Medknow Publications

More information

Scope and Contents

Contents

Background: The present work was planned to evaluate the antihyperglycemic, lipid-lowering, and antioxidant effect of Lactobacillus casei and Bifidobacterium bifidum in streptozotocin (STZ)-induced diabetic rats.
Methods: Single daily dose of 1 × 10 7 cfu/ml of L. casei and B. bifidum alone and in combination of both was given to Wistar rats ora...

Alternative Titles

Full title

Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipidemia, and oxidative stress in diabetic rats

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_811b660f49504906b2cb44528d6f672b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_811b660f49504906b2cb44528d6f672b

Other Identifiers

ISSN

2008-7802

E-ISSN

2008-8213

DOI

10.4103/2008-7802.188870

How to access this item